NEW: Find Out Why We're Different

Recently Registered: Yale University | Lexicon Pharmaceuticals | Protagonist Therapeutics | Flagship Pioneering

Novo Nordisk posts strong 2026 start and Wegovy pill surge: Wegovy pill surpasses 2 million prescriptions since January launch 

Obesity has officially overtaken oncology as largest contributor to biopharma pipeline value for first time in deloitte’s industry analysis, underscoring commercial momentum behind next-generation weight-loss therapies

Eli Lilly doubles down on its obesity franchise with a $4.5 billion expansion across its Indian manufacturing network